AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05985239 — intervention group
Intervention type: PROCEDURE
Intervention: VI
Description: Laparoscopic or robotic surgery with virtual ileostomy
Study NCT05985239 — intervention group
Intervention type: PROCEDURE
Intervention: DI
Description: Laparoscopic or robotic surgery with virtual ileostomy
Study NCT05868811 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Together
Description: The intervention consists of 45-minute weekly classes for 16 weeks. Each class is delivered by a trained Music Together facilitator and includes music activities such as singing, dancing, moving and playing musical instruments. At the start of the program, participants receive materials for home use that consist of a song book and online access code for song recordings used in the class.
Study NCT05868811 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Play Group
Description: The play group consists of 45-minute weekly classes for 16 weeks. During each class parents are encouraged to play with their child and interact with other participants using the provided age appropriate toys. At the start of the program participants receive an age appropriate toy for use at home.
Study NCT05593341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Opioid education in person
Description: The presentation and handouts contain information regarding the following topics:~* Reviewing opioids and strategies for analgesia~  * Defining and identifying opioids~ * Goals for postoperative pain management and utilizing opioids to treat pain~ * Alternative modes of treating pain~ * Regional anesthesia/analgesia defined~* Side effects and risks of opioids~  * Common side effects of opioids~ * Risks of addiction, tolerance, dependence, opioid-induced hyperalgesia with long-term use~* Proper use and handling of opioids~  * Safe practices when taking opioids~ * Weaning off opioids~ * Safe storage and disposal of opioids
Study NCT05593341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Opioid education via video
Description: The video and handouts contain information regarding the following topics:~* Reviewing opioids and strategies for analgesia~  * Defining and identifying opioids~ * Goals for postoperative pain management and utilizing opioids to treat pain~ * Alternative modes of treating pain~ * Regional anesthesia/analgesia defined~* Side effects and risks of opioids~  * Common side effects of opioids~ * Risks of addiction, tolerance, dependence, opioid-induced hyperalgesia with long-term use~* Proper use and handling of opioids~  * Safe practices when taking opioids~ * Weaning off opioids~ * Safe storage and disposal of opioids
Study NCT04842734 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical exercise and computerized cognitive training
Description: SPEP are planned for 12 weeks, 2 times a week, once a day, 60 minutes / 1 hour. The CCSP is planned for 12 weeks, minimum 3 to maximum 5 days a week, approximately 10 minutes, for a total of 36-60 sessions
Study NCT05049512 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multi-nut OIT
Description: Finely ground pure peanut, almond, cashew, hazelnut, and walnut.
Study NCT06257238 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fully immersive Head-Mounted Display Virtual Reality
Description: patients are asked to wear the Oculus Quest VR on their heads and to hold the hand controllers by their hands and start the game exercises (Dance loop, Tennis ball and Boxing) with 10 min. for each game with 1 min. rest in between, plus the traditional PT program:(Active ROM exercise for shoulder, Stretching exercise for shoulder extensors, adductors and internal rotators muscles and Strengthening exercise for shoulder muscles) 2 sessions per week for 2 months.
Study NCT05633927 — intervention group
Intervention type: BIOLOGICAL
Intervention: SARS-CoV-2 Vaccine
Description: Analyse humoral and cellular response to SARS-CoV-2 Vaccine.
Study NCT05549362 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dial Health Research Study
Description: To evaluate the feasibility and efficacy of dietary intervention approaches to slow mechanisms of aging.
Study NCT05549362 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Dial Health Research Study
Description: To evaluate the feasibility and efficacy of dietary intervention approaches to slow mechanisms of aging.
Study NCT05634174 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirabegron
Description: Single dose, 100mg oral mirabegron
Study NCT06257238 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Physical Therapy Program
Description: patients are treated with Active ROM exercise for shoulder, Stretching exercise for shoulder extensors, adductors and internal rotators muscles and Strengthening exercise for shoulder muscles, 2 sessions per week for 2 months.
Study NCT06257238 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Traditional Physical Therapy Program
Description: patients are treated with Active ROM exercise for shoulder, Stretching exercise for shoulder extensors, adductors and internal rotators muscles and Strengthening exercise for shoulder muscles, 2 sessions per week for 2 months.
Study NCT05715021 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bankart + Remplissage Procedure
Description: Participants will undergo arthroscopic stabilization.
Study NCT05743621 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TVB-2640
Description: TVB- 2640 at 100 mg, 150mg, 200 mg, 250 mg, or 300mg daily, orally; dose determined by BOIN dose escalation per the protocol
Study NCT05743621 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Description: 160 mg daily PO
Study NCT04943757 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine Hydrochloride
Description: 50 mg/m2 iv Days +3 through +4 after allogeneic hematopoietic stem cell transplantation
Study NCT04943757 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamid
Description: 25 mg/kg iv Days +3 through +4 after allogeneic hematopoietic stem cell transplantation
Study NCT05479812 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: WTX-124
Description: Investigation Product Monotherapy
Study NCT05550480 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring
Description: Continuous glucose monitoring for 50 days
Study NCT06409637 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOLFOX4 regimen
Description: FOLFOX4 regimen: Oxaliplatin 85mg/m2 intravenous infusion over 2 hours on Day 1; Leucovorin 400mg/m2 intravenous infusion over 2 hours on Days 1-2; 5-Fluorouracil (5-FU) initially 400mg/m2 intravenous bolus followed by 2400mg/m2 continuous intravenous infusion over 46 hours. Each cycle lasts for 4 weeks, repeated every 4 weeks for a total of 6-8 cycles.
Study NCT06409637 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lenvatinib
Description: Lenvatinib: For patients with a body weight \<60 kg, the recommended daily dose of lenvatinib is 8 mg (2 capsules of 4 mg each), once daily; for patients with a body weight ≥60 kg, the recommended daily dose of lenvatinib is 12 mg (3 capsules of 4 mg each), once daily. Treatment should be continued until disease progression, intolerable adverse effects, or the end of the study.
Study NCT04704102 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Muscle energy technique (MET)
Description: A manual therapy technique that uses the gentle muscle contractions of the patient to relax and lengthen muscles and normalize joint motion.
Study NCT04704102 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Strain-counterstrain (SCS)
Description: It's also called the positional release technique, a manual therapy technique that passively positions the hypertonic (spasmed) muscles and dysfunctional joints in positions of shortened or comfort.
Study NCT04704102 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: sham SCS
Description: SCS intervention that position with opposite site limb and direction, and with modified method as consider the easiness of a practitioner to press the tender points
Study NCT05479812 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pembrolizumab
Description: Investigation Product in combination with approved therapy
Study NCT06571682 — intervention group
Intervention type: DEVICE
Intervention: Target Controlled Infusion
Description: TCI (Target Controlled Infusion) is a method used to maintain the dose and rate of anesthesia drugs within a target concentration range set by the anesthetist. This system delivers drugs intravenously to the patient using a computer-controlled pump. The anesthetist adjusts the drug concentration to achieve the desired depth of anesthesia. This method provides more precise control over anesthesia and facilitates maintaining the depth of anesthesia within the desired range.
Study NCT06571682 — intervention group
Intervention type: DRUG
Intervention: Inhalation anesthetic
Description: In the inhalation anesthesia group, maintenance sevoflurane anesthesia will be applied after routine induction.
Study NCT04531579 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valproic Acid Solution
Description: Valproate sodium in 5-ml single-dose vials containing 100 mg/ml of VPA. The appropriate dose of 140 mg/kg, based on the subject's weight at study entry, will be diluted in isotonic saline solution to a final volume of 300 ml for administration
Study NCT04531579 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Isotonic saline solution
Description: Isotonic saline solution consisting of 0.9% sodium chloride in the volume of 300 ml for administration
Study NCT06571812 — intervention group
Intervention type: DEVICE
Intervention: TSX
Description: Treatment of tooth loss with TSX dental implants
Study NCT06263803 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music listening, classic physical therapy
Description: Participants will listen to the music pieces Pachabel Canon in D major (20 minutes) and Mozart - Sonata for Two Pianos in D, K. 448 (25 minutes), free from external sounds (max 70 dB through headphones).
Study NCT06263803 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Music listening, classic physical therapy
Description: Participants will listen to the music pieces Pachabel Canon in D major (20 minutes) and Mozart - Sonata for Two Pianos in D, K. 448 (25 minutes), free from external sounds (max 70 dB through headphones).
Study NCT05797376 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5mg
Description: patients are prescribed aspirin at a daily dose of 100mg and Rivaroxaban (2.5 mg twice a day)
Study NCT06297447 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PNE4Adults - pain science education
Description: Is formerly described under arm descriptions
Study NCT06297447 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Is formerly described under arm descriptions
Study NCT06015438 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home Exercise Program
Description: Participants will perform a minimum of one exercise from each of the targeted muscle groups at a frequency of every other day, for a total of 3-4 days a week of exercise with a rest day. The entire strengthening exercise routine should take approximately 25-30 minutes to perform, including rest periods. Each muscle grouping of exercises is designed to progress from minimal muscle effort required to moderate to maximal effort. Participants will use a video to perform the exercises as well as a handout with specific instructions.
Study NCT06015438 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Short Exercise Program
Description: Participants in this group will attend one in-person visit expected to last about 60 minutes. The clinic visit will consist of standard of care procedures and tests for individuals with mild-to-severe HS .
Study NCT05478837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV
Study NCT05478837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV
Study NCT05478837 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous Anti-H3.3K27M TCR-expressing T-cells
Description: Given IV
Study NCT06558175 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: stereotactic body radiation therapy (SBRT)
Description: Patients will be assigned to treatment doses using the TITE-CRM model.
Study NCT06565676 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bread with whey protein powder added
Description: Volunteer participants will consume bread with and without whey powder added and its effect on blood sugar will be examined.
Study NCT05704803 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Diagnostic Test: IN Vitro
Description: In vitro diagnostic test for COVID-19 using anterior nasal swabs.
Study NCT06213480 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Synbiotic Group
Description: WBF-038: Noninfectious and nonhazardous lyophilized commensal bacteria (probiotics). Contains no genetically modified organisms (GMOs) and contains no animal ingredients or by-products, and were originally isolated from human sources. The (probiotic) strains are grown in a FDA registered food facility, adhering to Good Manufacturing Practice (GMP) conditions.~Probiotic Ingredients:~Clostridium butyricum WBSTR-0006, Clostridium beijerinckii WB-STR-0005, Anaerobutyricum hallii WB-STR-0008, Akkermansia muciniphila WBSTR-0001, and Bifidobacterium infantis~The product also contains: Chicory inulin and oligofructose (prebiotic fiber), hypromellose (vegetarian capsule), fruit \& vegetable juice (coloring agent), magnesium stearate and silica (flow agent for encapsulation)
Study NCT06213480 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Group
Description: Ingredients: Chicory inulin and oligofructose (prebiotic fiber, hypromellose (vegetarian capsule), fruit \& vegetable juice (coloring agent), magnesium stearate and silica (flow agent for encapsulation).
Study NCT05078411 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Test treatment
Description: Test treatment will consist of a single session structured as follows: (i) information on periodontal diagnosis (as formulated according to the classification system of the 2017 World Workshop for the Classification of Periodontal Diseases and Conditions); (ii) information on periodontal risk level (as calculated with the PerioRisk tool proposed by Trombelli et al. 2009) and profile (i.e., the magnitude of the contribution of each PerioRisk parameter to generate the patient risk level); (iii) information on treatment plan and oral hygiene instructions, with emphasis to treatment goals based on the PerioRisk output.~The operators will be trained to administer test treatment in approximately 8 minutes, but the duration of the session will be extended for additional questions and answers upon patient request.
Study NCT05078411 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Control treatment
Description: Control treatment will consist in a single session structured as follows: (i) information on periodontal diagnosis (as formulated according to the classification system of the 2017 World Workshop for the Classification of Periodontal Diseases and Conditions); (ii) information on treatment plan and oral hygiene instructions, and treatment goals. Although the general concept of risk of periodontitis incidence/progression will be explained, no mention will be made to the patient risk level as calculated with PerioRisk or any other tool.~The operators will be trained to administer control treatment in approximately 8 minutes, but the duration of the session will be extended for additional questions and answers upon patient request.
Study NCT04741971 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotics group
Description: Will give Probiotics with Vitamin D3 one drop per day for 90 days
Study NCT04741971 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Non-probiotics group
Description: Will give Vitamin D3 five drops per day for 90 days
Study NCT06179095 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality
Description: Participants will view a specific relaxing and distracting scenario using virtual reality (VR) for approximately 7-8 minutes from one minute before the procedure until the end of the procedure. Assessment will be performed with STAI just before the intrauterine device insertion procedure, and again with STAI after the procedure.
Study NCT05786326 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: group 1
Description: Insertion of fully covered self-expanding metallic stents with multi-holes (FCSEMS- MH) Biliary stent HANAROSTENT® CCC (M.I.Tech Co., Ltd, pyeongtaek, Korea) in a biliary tree through endoscopic retrograde cholangiopancreatography (ERCP) under general anesthesia by expertise in patients with malignant biliary obstruction
Study NCT05786326 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: group 2
Description: Insertion of partially covered self-expanding metallic stents HANAROSTENT® Biliary (NCN) in the biliary tree through ERCP under general anesthesia by Expertise in patients with malignant biliary obstruction.
Study NCT05786326 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: group 3
Description: Insertion of uncovered self-expanding metallic stents (Biliary stent HANAROSTENT® NNN) (M.I.Tech Co., Ltd. Pyeongtaek, Korea) in a biliary tree through ERCP under general anesthesia by Expertise in patients with malignant biliary obstruction.
Study NCT05634200 — intervention group
Intervention type: PROCEDURE
Intervention: Bronchoscopy
Description: During bronchoscopy endobronchial biopsy, transbronchial biopsy, transbronchial needle aspiration, bronchial washing, bronchoalveolar lavage, EBUS-TBNA and EUS-B-FNA may be performed
Study NCT05336695 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PET/MR Imaging
Description: PET/MRI Scan with \[64Cu\]FBP8 as directed by protocol
Study NCT05336695 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 64Cu-FBP8
Description: Will be administered by intravenous injection by bolus by a qualified nuclear medicine technician at the Martinos Center
Study NCT05935085 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANB032
Description: BTLA agonist antibody
Study NCT05935085 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06207942 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Feed back controlled temperature device
Description: If core temperature exceeds 37.7 degrees celsius a feedback controlled-device will be used at set to 37.5 degrees celsius
Study NCT06207942 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High MAP
Description: A mean arterial blood pressure (MAP) of >85mmHg will be used. Vasopressors will be titrated to this target during 36 hours
Study NCT06207942 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Deep sedation
Description: Deep sedation for at least 36 hours
Study NCT06207942 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fever control without a device
Description: Management of fever in the intensive care unit without a device
Study NCT06207942 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low MAP
Description: A mean arterial blood pressure (MAP) of >65mmHG will be used. Vasopressors will be titrated to this target during 36 hours
Study NCT06207942 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Minimal sedation
Description: A strategy of minimal sedation in the intensive care unit, used only as needed to facilitate transport, imaging and invasive procedures
Study NCT05425121 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Core stability exercises
Description: The intervention in the control group will core stability exercises for different back muscles and strengthening exercises of Gluteal Muscles.
Study NCT05425121 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Core stability exercises
Description: The intervention in the control group will core stability exercises for different back muscles and strengthening exercises of Gluteal Muscles.
Study NCT06317272 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: DIBH using ABC technique
Description: Deep breath inspiration hold (DIBH) using Active Breathing Control (ABC) technique
Study NCT06317272 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DIBH using VC technique
Description: Deep breath inspiration hold (DIBH) using Voluntary Coaching (VC) technique
Study NCT05425121 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biofeedback training
Description: EMG biofeedback training will be administered to the participants in combination with core stability exercise training.
Study NCT04958096 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standard Therapeutic Deep Brain Stimulation
Description: DBS to the standard subcortical targets (anterior limb of the internal capsule- ALIC) will be used to treat OCD
Study NCT04958096 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cortical Stimulation for PFC
Description: Patients enrolled in this study will have a second pair of leads placed in the prefrontal cortex (PFC) bilaterally as well the surrounding white matter tracts and stimulation will be delivered through these leads to improve OCD symptoms
Study NCT04958096 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cortical Stimulation for ACC
Description: Patients enrolled in this study will have a second pair of leads placed in the anterior cingulate cortex (ACC) bilaterally as well the surrounding white matter tracts and stimulation will be delivered through these leads to improve OCD symptoms